Selected research
Industry Research
Membrane Filtration Pharmaceutical Sterility Testing Industry Research Report 2026
Market perspective
The global Membrane Filtration Pharmaceutical Sterility Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Membrane Filtration Pharmaceutical Sterility Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Membrane Filtration Pharmaceutical Sterility Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Membrane Filtration Pharmaceutical Sterility Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Membrane Filtration Pharmaceutical Sterility Testing include Steris PLC, Charles River Laboratories International, Inc., Thermo Fisher Scientific, Inc., SGS S.A., Sartorius AG, Sotera Health Company, Pacific Biolabs, Inc., Laboratory Corporation of America Holdings and Almac Group and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Membrane Filtration Pharmaceutical Sterility Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Membrane Filtration Pharmaceutical Sterility Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Membrane Filtration Pharmaceutical Sterility Testing Market by Company
Steris PLC
Charles River Laboratories International, Inc.
Thermo Fisher Scientific, Inc.
SGS S.A.
Sartorius AG
Sotera Health Company
Pacific Biolabs, Inc.
Laboratory Corporation of America Holdings
Almac Group
Pace Analytical Services, LLC
Membrane Filtration Pharmaceutical Sterility Testing Segment by Type
Bioburden Testing
Sterility Testing
Bacterial Endotoxin Testing
Membrane Filtration Pharmaceutical Sterility Testing Segment by Application
Pharmaceuticals
Medical Devices
Biopharmaceuticals
Membrane Filtration Pharmaceutical Sterility Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Membrane Filtration Pharmaceutical Sterility Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Membrane Filtration Pharmaceutical Sterility Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Membrane Filtration Pharmaceutical Sterility Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Membrane Filtration Pharmaceutical Sterility Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Bioburden Testing
- Sterility Testing
- Bacterial Endotoxin Testing
Applications
- Pharmaceuticals
- Medical Devices
- Biopharmaceuticals
Companies covered
- Steris PLC
- Charles River Laboratories International, Inc.
- Thermo Fisher Scientific, Inc.
- SGS S.A.
- Sartorius AG
- Sotera Health Company
- Pacific Biolabs, Inc.
- Laboratory Corporation of America Holdings
- Almac Group
- Pace Analytical Services, LLC
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Membrane Filtration Pharmaceutical Sterility Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Bioburden Testing
- 2.2.3 Sterility Testing
- 2.2.4 Bacterial Endotoxin Testing
- 2.3 Membrane Filtration Pharmaceutical Sterility Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals
- 2.3.3 Medical Devices
- 2.3.4 Biopharmaceuticals
- 2.4 Assumptions and Limitations
3 Membrane Filtration Pharmaceutical Sterility Testing Breakdown Data by Type
- 3.1 Global Membrane Filtration Pharmaceutical Sterility Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Membrane Filtration Pharmaceutical Sterility Testing Forecasted Market Size by Type (2027-2032)
4 Membrane Filtration Pharmaceutical Sterility Testing Breakdown Data by Application
- 4.1 Global Membrane Filtration Pharmaceutical Sterility Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Membrane Filtration Pharmaceutical Sterility Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Membrane Filtration Pharmaceutical Sterility Testing Market Perspective (2021-2032)
- 5.2 Global Membrane Filtration Pharmaceutical Sterility Testing Growth Trends by Region
- 5.2.1 Global Membrane Filtration Pharmaceutical Sterility Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Membrane Filtration Pharmaceutical Sterility Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Membrane Filtration Pharmaceutical Sterility Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Membrane Filtration Pharmaceutical Sterility Testing Market Dynamics
- 5.3.1 Membrane Filtration Pharmaceutical Sterility Testing Industry Trends
- 5.3.2 Membrane Filtration Pharmaceutical Sterility Testing Market Drivers
- 5.3.3 Membrane Filtration Pharmaceutical Sterility Testing Market Challenges
- 5.3.4 Membrane Filtration Pharmaceutical Sterility Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Membrane Filtration Pharmaceutical Sterility Testing Players by Revenue
- 6.1.1 Global Top Membrane Filtration Pharmaceutical Sterility Testing Players by Revenue (2021-2026)
- 6.1.2 Global Membrane Filtration Pharmaceutical Sterility Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Membrane Filtration Pharmaceutical Sterility Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Membrane Filtration Pharmaceutical Sterility Testing Head Office and Area Served
- 6.4 Global Membrane Filtration Pharmaceutical Sterility Testing Players, Product Type & Application
- 6.5 Global Membrane Filtration Pharmaceutical Sterility Testing Manufacturers Established Date
- 6.6 Global Membrane Filtration Pharmaceutical Sterility Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Membrane Filtration Pharmaceutical Sterility Testing Market Size (2021-2032)
- 7.2 North America Membrane Filtration Pharmaceutical Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2021-2026)
- 7.4 North America Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Membrane Filtration Pharmaceutical Sterility Testing Market Size (2021-2032)
- 8.2 Europe Membrane Filtration Pharmaceutical Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2021-2026)
- 8.4 Europe Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Membrane Filtration Pharmaceutical Sterility Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Membrane Filtration Pharmaceutical Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Membrane Filtration Pharmaceutical Sterility Testing Market Size (2021-2032)
- 10.2 South America Membrane Filtration Pharmaceutical Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2021-2026)
- 10.4 South America Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Membrane Filtration Pharmaceutical Sterility Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Steris PLC
- 12.1.1 Steris PLC Company Information
- 12.1.2 Steris PLC Business Overview
- 12.1.3 Steris PLC Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.1.4 Steris PLC Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.1.5 Steris PLC Recent Developments
- 12.2 Charles River Laboratories International, Inc.
- 12.2.1 Charles River Laboratories International, Inc. Company Information
- 12.2.2 Charles River Laboratories International, Inc. Business Overview
- 12.2.3 Charles River Laboratories International, Inc. Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.2.4 Charles River Laboratories International, Inc. Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.2.5 Charles River Laboratories International, Inc. Recent Developments
- 12.3 Thermo Fisher Scientific, Inc.
- 12.3.1 Thermo Fisher Scientific, Inc. Company Information
- 12.3.2 Thermo Fisher Scientific, Inc. Business Overview
- 12.3.3 Thermo Fisher Scientific, Inc. Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.3.4 Thermo Fisher Scientific, Inc. Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.3.5 Thermo Fisher Scientific, Inc. Recent Developments
- 12.4 SGS S.A.
- 12.4.1 SGS S.A. Company Information
- 12.4.2 SGS S.A. Business Overview
- 12.4.3 SGS S.A. Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.4.4 SGS S.A. Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.4.5 SGS S.A. Recent Developments
- 12.5 Sartorius AG
- 12.5.1 Sartorius AG Company Information
- 12.5.2 Sartorius AG Business Overview
- 12.5.3 Sartorius AG Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.5.4 Sartorius AG Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.5.5 Sartorius AG Recent Developments
- 12.6 Sotera Health Company
- 12.6.1 Sotera Health Company Company Information
- 12.6.2 Sotera Health Company Business Overview
- 12.6.3 Sotera Health Company Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.6.4 Sotera Health Company Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.6.5 Sotera Health Company Recent Developments
- 12.7 Pacific Biolabs, Inc.
- 12.7.1 Pacific Biolabs, Inc. Company Information
- 12.7.2 Pacific Biolabs, Inc. Business Overview
- 12.7.3 Pacific Biolabs, Inc. Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.7.4 Pacific Biolabs, Inc. Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.7.5 Pacific Biolabs, Inc. Recent Developments
- 12.8 Laboratory Corporation of America Holdings
- 12.8.1 Laboratory Corporation of America Holdings Company Information
- 12.8.2 Laboratory Corporation of America Holdings Business Overview
- 12.8.3 Laboratory Corporation of America Holdings Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.8.4 Laboratory Corporation of America Holdings Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.8.5 Laboratory Corporation of America Holdings Recent Developments
- 12.9 Almac Group
- 12.9.1 Almac Group Company Information
- 12.9.2 Almac Group Business Overview
- 12.9.3 Almac Group Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.9.4 Almac Group Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.9.5 Almac Group Recent Developments
- 12.10 Pace Analytical Services, LLC
- 12.10.1 Pace Analytical Services, LLC Company Information
- 12.10.2 Pace Analytical Services, LLC Business Overview
- 12.10.3 Pace Analytical Services, LLC Revenue in Membrane Filtration Pharmaceutical Sterility Testing Business (2021-2026)
- 12.10.4 Pace Analytical Services, LLC Membrane Filtration Pharmaceutical Sterility Testing Product Portfolio
- 12.10.5 Pace Analytical Services, LLC Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst